A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

Clinical trial NCT00149851 · COMPLETED

Trial details

NCT number: NCT00149851
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Symptomatic Gastroespohageal Reflux Disease

Start date: 2004-01-01
Primary completion: 2005-06-01
Enrollment: 832

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.